Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039758 | SCV000063447 | benign | not specified | 2015-06-03 | criteria provided, single submitter | clinical testing | Val1800Ile in exon 33 of PCDH15: This variant is not expected to have clinical s ignificance because it has been identified in 0.7% (94/13018) of South Asian chr omosomes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, htt p://exac.broadinstitute.org; dbSNP rs111033463). In addition, the valine (Val) residue at position 1800 is not conserved in several species, with chimpanzee an d macaque having an isoleucine (Ile) at this position. |
Counsyl | RCV000169085 | SCV000220261 | likely benign | Usher syndrome type 1F | 2014-04-21 | criteria provided, single submitter | literature only | |
Genomic Diagnostic Laboratory, |
RCV000039758 | SCV000297036 | likely benign | not specified | 2015-10-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000896182 | SCV000726560 | benign | not provided | 2020-05-15 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27984600, 22135276) |
Invitae | RCV000896182 | SCV001040262 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000896182 | SCV001249007 | likely benign | not provided | 2019-12-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001105924 | SCV001262939 | likely benign | Usher syndrome type 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Fulgent Genetics, |
RCV002477117 | SCV002797316 | benign | Autosomal recessive nonsyndromic hearing loss 23; Usher syndrome type 1D; Usher syndrome type 1F | 2022-05-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004534845 | SCV004753106 | likely benign | PCDH15-related disorder | 2019-07-22 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV000169085 | SCV001454381 | benign | Usher syndrome type 1F | 2020-04-13 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000896182 | SCV001923711 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000896182 | SCV001968443 | likely benign | not provided | no assertion criteria provided | clinical testing |